Search Results

You are looking at 81 - 90 of 793 items for :

  • "screening" x
Clear All
Full access

Doralina L. Anghelescu, Jennifer Harman Ehrentraut and Lane G. Faughnan

/misuse behaviors. Regardless, the currently accepted approach for screening and risk stratification of patients undergoing COT is based on the principle of “universal precautions.” No patients are considered risk-free; treatment with opioid medications, which have

Full access

Elisabeth Kenne Sarenmalm, Salmir Nasic, Cecilia Håkanson, Joakim Öhlén, Eva Carlsson, Monica E. Pettersson and Richard Sawatzky

recommends that all patients be routinely screened for distress at appropriate intervals during the cancer trajectory, 6 and the Distress Thermometer (DT) has been shown to be an effective screening tool in identifying distress in patients with cancer. 6 , 7

Full access

Steven C. Palmer

In this issue of JNCCN , Schuurhuizen et al 1 provide an opportunity to examine some assumptions about screening and intervening for psychosocial distress among patients with cancer. In their study, 349 individuals with metastatic colorectal

Full access

Sarah P. Hammond, Sankar Swaminathan, William I. Bensinger and Lindsey R. Baden

rituximab and ofatumumab have black box warnings about the risk for HBV reactivation leading to liver failure and death. Thus, screening for HBV before treatment is recommended. The rate of reactivation among patients treated with rituximab

Full access

Robert J. Morgan

diagnosis through large population-based screening programs. Unfortunately, due to the lack of both sensitive and specific testing approaches for early-stage disease, these have been largely unsuccessful. 2 – 4 Most recently, early results from the

Full access

Andrea Feldstain, Barry D. Bultz, Janet de Groot, Amane Abdul-Razzak, Leonie Herx, Lyle Galloway, Srini Chary and Aynharan Sinnarajah

have upcoming appointments at TBCC, they could schedule an appointment at the CCMS weekly half-day clinic. At the clinic, they met with a physician, pharmacist, and psychosocial clinician. All patients had completed screening for distress (SFD) measures

Full access

Jimmie C. Holland

was conducted more than 10 years ago, showed the need to identify high-risk patients through psychosocial screening to provide early intervention. 1 In 1997, NCCN took a proactive step, appointing a multidisciplinary panel from each member

Full access

Peter H. Carroll and James L. Mohler

“There may be a cancer subject that is more controversial than the screening and early detection of prostate cancer, but I don't know what that is,” said Peter H. Carroll, MD, MPH, Professor and Chair, Department of Urology, UCSF Helen Diller

Full access

Benjamin O. Anderson and Robert W. Carlson

. 3. Jemal A Murray T Ward E . Cancer statistics, 2005 . CA Cancer J Clin 2005 ; 55 : 10 – 30 . 4. Vainio H . IARC Handbooks of Cancer Prevention: Breast Cancer Screening . Lyon, France : IARCPress , 2002 . 5. Parkin

Full access

Antonio Di Meglio, Nancy U. Lin, Rachel A. Freedman, William T. Barry, Eric P. Winer and Ines Vaz-Luis

−/HER2−, and very uncommonly with HR+/HER2− breast cancer, had brain metastases on initial staging; of these, 6 were asymptomatic at the time of CNS screening: 5 of 6 and 1 of 6 patients had ≥5 and <5 brain metastases, respectively. Baseline TM testing